CD44 and B-cell chronic lymphocytic leukemia: A second promising candidate in CLL is the anti-CD44 antibody RG7356 (also known as RO5429083 or ARH460-16-2), a humanized antibody targeting a glycosylated, extracellular constant region of CD44 (86).